Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) saw strong trading volume on Thursday . 59,802 shares were traded during trading, an increase of 382% from the previous session’s volume of 12,395 shares.The stock last traded at $10.97 and had previously closed at $11.12.
Santen Pharmaceutical Trading Down 0.7%
The stock has a market capitalization of $3.67 billion and a P/E ratio of 0.10. The business’s fifty day simple moving average is $10.96 and its two-hundred day simple moving average is $10.62.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan?based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over?the?counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post?operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Further Reading
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
